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Abstract: Neurology is often not 
discussed in lifestyle medicine circles, 
but it might be an area that will 
propel the cause of lifestyle medicine 
in the future. This is especially 
relevant in increasingly common 
neurodegenerative conditions such 
as Alzheimer’s disease, which have 
no known disease modifying therapy 
but lifestyle factors are implicated in 
causation.
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I can think of no other disease that 
has such a profound effect on loss of 
function, loss of independence, and 
the need for care. I can think of no 
other disease so deeply dreaded by 
anyone who wants to age gracefully 
and with dignity. I can think of no 
other disease that places such a 
heavy burden on families, 
communities, and societies. I can 
think of no other disease where 
innovation, including breakthrough 
discoveries to develop a cure, is so 
badly needed.
—Dr Margaret Chan, Director-General of 
the World Health Organization, at the 
Conference on Global Action Against 
Dementia, March 20151
In an article titled “A Tale of Coronary 
Artery Disease and Myocardial 
Infarction,” published in the celebratory 
200th year edition of the New England 
Journal of Medicine, the authors shared a 
success story.2 They presented data 
showing a decline in cardiovascular 
mortality and hinted toward an optimistic 
outlook, predicated on innovations in 
surgical and pharmacological 
interventions. Glaringly absent in the 
article was the evidence-base for lifestyle 
interventions in the primary, secondary, 
and tertiary prevention of cardiovascular 
conditions. Indeed, one of the greatest 
impediments to the widespread 
acceptance and embrace of lifestyle 
medicine for the prevention and 
treatment of cardiovascular disease is the 
availability of other options.
However, when it comes to 
neurodegenerative conditions such as 
dementia, the prevalence and burden of 
which is rising sharply, treatment 
options are lacking. Encouragingly, the 
evidence-base for lifestyle as therapy is 
emerging.
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When it comes to  
neurodegenerative conditions such 
as dementia, . . . treatment options 
are lacking. Encouragingly, the 
evidence-base for lifestyle as 
therapy is emerging.
DOI: 10.1177/1559827616664715.  From the Lifestyle Research Centre, Avondale College of Higher Education, Cooranbong, New South Wales, Australia. Address cor-
respondence to Bruce Thompson, Lifestyle Research Centre, Avondale College of Higher Education, 582 Freemans Drive, Cooranbong, New South Wales 2265, Australia; 
e-mail: s15171957@student.avondale.edu.au.
For reprints and permissions queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.
Copyright © 2016 The Author(s)
 at Avondale College on August 28, 2016ajl.sagepub.comDownloaded from 
2
Mon • Mon XXXXAmerican Journal of Lifestyle Medicine
Alzheimer’s is the only disease in the 
top 10 causes of death in the United 
States to rise in the past decade.3 In 
2014, the prevalence of diagnosed 
Alzheimer’s rose by 10%, making it now 
the sixth leading cause of death.4 In 
Australia, if present trends continue, 
dementia will overtake coronary heart 
disease as the leading cause of death 
within 5 years.5 Indeed, the 21st century 
is being referred to as “the century of 
neurodegeneration.”6 As the statistics 
escalate, the medical profession, from 
primary care physicians and geriatricians 
to researchers,7 and even the World 
Health Organization (see opening quote) 
are frustrated by the lack of any effective 
therapies.
The rise of neurological diseases, 
specifically dementia, may present 
lifestyle medicine with a unique 
opportunity to receive the prominence it 
deserves. Dementia is “a relentlessly 
progressive terminal illness”6 for which 
there are no surgical or pharmacological 
treatment options. However, there is 
good evidence that a healthy lifestyle is 
protective against the condition.
As much as one third of Alzheimer’s 
disease is attributable to modifiable risk 
factors, most of which have lifestyle 
underpinnings: physical inactivity, 
smoking, hypertension, obesity, 
diabetes, and depression.8 Furthermore, 
the pathogenesis of Alzheimer’s disease 
implicates lifestyle-induced vascular 
lesions and poor perfusion, to the 
extent that Alzheimer’s is now 
considered a combination of 
cardiovascular disease and 
neurodegeneration.9 Alzheimer’s has 
also been referred to as “type 3 
diabetes”10 because of the similarities in 
the risk factors, metabolic disorder, and 
pathology of the two conditions.11 As 
with other chronic conditions, 
inflammation and oxidative stress have 
been identified as underpinning the 
progression of neurodegeneration.12 
These findings highlight the lifestyle 
connection to neurodegenerative 
conditions, and it is becoming 
increasingly clear that a healthy lifestyle 
can prevent Alzhiemer’s.13
Furthermore, there is emerging 
evidence that healthy lifestyle practices 
may be effective in the management and 
even treatment of dementia and its 
associated symptoms. In an article titled 
“Why Has Therapy Development for 
Dementia Failed in the Last Two 
Decades?”7 Gauthier and associates 
conclude that the only “encouraging new 
data” was from the Finnish Geriatric trial 
where cognitive decline in at-risk 
individuals was reduced by diet, exercise, 
cognitive training, and vascular risk 
monitoring.14 This large study has lent 
support to the results of a small study of 
10 subjects with dementia where a 
complex intervention incorporating a 
healthy diet, sleep hygiene, physical 
activity, stress management, and 
nutritional supplements resulted in all but 
one subject experiencing sustained 
improvement in cognition and reversal of 
memory loss.15
Are we are at the stage today with 
neurodegenerative conditions that we 
were at 35 years ago with cardiovascular 
disease, when Ornish and colleagues16 
showed the viability of intensive 
therapeutic lifestyle change?
For many years we have received 
unsolicited reports from participants 
in the Complete Health Improvement 
Program (CHIP)17 of a “fog lifting 
from my brain.” Presently we are 
investigating this phenomenon  
further by exploring changes in 
cognitive function and decline in 
response to CHIP (ANZCTR 
ACTRN12616000720415),18 but what 
has been intriguing in conducting the 
trial is the receptiveness of both 
participants and medical practitioners. 
Faced with cognitive decline and a 
daunting prognosis, participants 
demonstrated a high readiness for 
change, while medical practitioners, 
recognizing the dearth of treatment 
options, have been refreshingly 
receptive to lifestyle medicine.
Neurology is often not discussed in 
lifestyle medicine circles, but it might be 
an area that will propel the cause of 
lifestyle medicine in the future. So as we 
champion lifestyle medicine moving 
forward, let us not forget about  
the brain. AJLM
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